Edotreotide gallium Ga-68
- Generic Name
- Edotreotide gallium Ga-68
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C65H89GaN14O18S2
- CAS Number
- 2101630-92-4
- Unique Ingredient Identifier
- Y68179SY2L
- Background
Edotreotide gallium Ga-68 is an 8 amino acid peptide bound to the chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA). Edotreotide gallium Ga-68 is indicated for localizing somatostatin receptor positive neuroendocrine tumors by positron emission tomography. Dotatate gallium Ga-68 is used for a similar indication. Dotatate gallium Ga-68 has lower tumor uptake but this data is highly variable between patients.
Edotreotide gallium Ga-68 was granted FDA approval on 21 August 2019.
- Indication
Edotreotide gallium Ga-68 is a radioactive diagnostic compound used in positron emission tomography (PET) for diagnose somatostatin receptor positive neuroendocrine tumors in pediatrics and adults.
- Associated Conditions
- Neuroendocrine Tumors
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.